Fibrosis, Liver
Fibrosis, Liver
Explore linked clinical trials. Standard reference: MESH:M001263762 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06632444 | |
| Nutritional Indices and Inflammatory Markers in MASLD | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, nutritional deficiency disease, nutritional disorder | Not yet recruiting | Not stated | 2026-09-22 | NCT07834905 | |
| Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, endocrine system disorder, fatty liver disease, hypothyroidism, liver disorder, metabolic dysfunction-associated steatotic liver disease, thyroid gland disorder | Not yet recruiting | Not stated | 2026-09-18 | NCT07827430 | |
| Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary atresia, biliary tract disorder, cirrhosis of liver, liver disorder | Recruiting | Phase 1 | 2026-09-09 | NCT07797673 | |
| Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Phase 2 | 2026-09-01 | NCT07610837 | |
| Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Trematode Infections, cirrhosis of liver, helminthiasis, liver disorder, parasitic infectious disease, portal hypertension, schistosomiasis, vector-borne disease | Not yet recruiting | Phase 2 / Phase 3 | 2026-08-12 | NCT07754617 | |
| Isocaloric Navy-Bean Substitution in Adults With MASLD | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Not yet recruiting | Not applicable | 2026-08-12 | NCT07730853 | |
| Liver Cancer Prevention Randomized Control Trial | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Active, not recruiting | Not applicable | 2026-08-12 | NCT05196867 | |
| Fibrosis Lessens After Metabolic Surgery | Body Weight, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 4 | 2026-07-31 | NCT06374875 | |
| Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Fibrosis, Fibrosis, Liver, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, cirrhosis of liver, fatty liver disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, viral hepatitis, viral infectious disease | Not yet recruiting | Not stated | 2026-07-21 | NCT07716384 | |
| Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 2 | 2026-07-17 | NCT06005012 | |
| Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Not applicable | 2026-06-30 | NCT05699018 | |
| Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial | Body Weight, Body Weight Changes, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Insulin Resistance, Insulin Sensitivity, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-06-25 | NCT06138821 | |
| Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme | Body Weight, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Not stated | 2026-06-22 | NCT07658755 | |
| Screening for Chronic Liver Diseases in General Population | Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Fibrosis, Liver, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, cirrhosis of liver, epithelial neoplasm, fatty liver disease, hepatocellular carcinoma, liver disorder, metabolic dysfunction-associated steatotic liver disease, neoplasm | Active, not recruiting | Not applicable | 2026-06-22 | NCT06366425 | |
| Patients With Primary Biliary Cholangitis(PBC) | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, glucose metabolism disease, hyperglycemia, intrahepatic cholestasis, liver disorder, metabolic disease, primary biliary cholangitis | Active, not recruiting | Not stated | 2026-06-05 | NCT07629128 | |
| Interventional AI-Human Collaboration for Steatotic Liver Disease Screening | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, liver disorder | Enrolling by invitation | Not applicable | 2026-05-29 | NCT07613827 | |
| Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, immune system disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, type 1 diabetes mellitus | Active, not recruiting | Not stated | 2026-05-29 | NCT04595474 | |
| HIBOC = Hepatic Imaging Biomarkers in Obese Children | Body Weight, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, cirrhosis of liver, disease, fatty liver disease, hepatitis, liver disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Enrolling by invitation | Not stated | 2026-05-18 | NCT06463223 | |
| Sonazoid CEUS for Early HCC Surveillance | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Not yet recruiting | Not applicable | 2026-05-15 | NCT07590284 | |
| Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Not stated | 2026-05-15 | NCT07588854 | |
| COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER | Constriction, Pathologic, Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Fibrosis, Liver, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, fatty liver disease, intestinal disorder, liver disorder, neoplasm, rectal disorder | Recruiting | Phase 1 / Phase 2 | 2026-05-05 | NCT05692024 | |
| Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) | Body Weight, Digestive System Diseases, Dyslipidemias, Fibrosis, Fibrosis, Liver, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Enrolling by invitation | Phase 4 | 2026-04-21 | NCT06845345 | |
| Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD) | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Not stated | 2026-04-15 | NCT07530419 | |
| Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease | Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Fibrosis, Liver, Liver Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, neoplasm | Recruiting | Not stated | 2026-04-14 | NCT07265544 |